Cardiol Therapeutics Inc. (TSX:CRDL), a biotechnology company developing proprietary formulations that will treat life-threatening diseases, was featured on BNN Bloomberg’s Market Call with Robert McWhirter. Cardiol uses CBD in its drug formulations due to CBDs anti-inflammatory properties, which could help reduce inflammation in human hearts. The company has teamed up with the University of Alberta to develop an encapsulation process that utilizes nanotechnology to enhance the compatibility of the drugs with the aqueous blood circulation, improve pharmacokinetics and increase drug concentration at the site of disease.

Cardiol also has a partnership with Noramco, a global leader in the manufacturing and supply of controlled drug substance APIs. Under its long-term, exclusive supply agreement, Cardiol will be able to manufacture and supply pure pharmaceutical CBD for Canada and Mexico. According to McWhirter, Cardiol believes that they will be able to produce one million grams of synthetic CBD within 2019, which will allow them to bypass provincial suppliers and licensed producers who are struggling to supply the Canadian cannabis market.


If Cardiol can produce one million grams of CBD and also negotiate supply agreements with Shoppers Drug Mart, for instance, McWhirter believes that the company will be able to meet their quota and start selling their drug formulation. He also thinks that Cardiol will be looking at establishing a US partner to capitalize on the hemp and CBD market there and meet the demand for cannabis-based therapies in both Canada and Mexico.

To view the full video, click here.

Click here to connect with Cardiol Therapeutics Inc. (TSX:CRDL) for an Investor Presentation. 

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less